189 related articles for article (PubMed ID: 17587571)
1. Synthesis and evaluation of a phosphonate analogue of the soluble guanylate cyclase activator YC-1.
Martin NI; Derbyshire ER; Marletta MA
Bioorg Med Chem Lett; 2007 Sep; 17(17):4938-41. PubMed ID: 17587571
[TBL] [Abstract][Full Text] [Related]
2. The design and synthesis of YC-1 analogues as probes for soluble guanylate cyclase.
Hering KW; Artz JD; Pearson WH; Marletta MA
Bioorg Med Chem Lett; 2006 Feb; 16(3):618-21. PubMed ID: 16326101
[TBL] [Abstract][Full Text] [Related]
3. Functional characterization of nitric oxide and YC-1 activation of soluble guanylyl cyclase: structural implication for the YC-1 binding site?
Lamothe M; Chang FJ; Balashova N; Shirokov R; Beuve A
Biochemistry; 2004 Mar; 43(11):3039-48. PubMed ID: 15023055
[TBL] [Abstract][Full Text] [Related]
4. Pharmacology of the nitric oxide receptor, soluble guanylyl cyclase, in cerebellar cells.
Bellamy TC; Garthwaite J
Br J Pharmacol; 2002 May; 136(1):95-103. PubMed ID: 11976273
[TBL] [Abstract][Full Text] [Related]
5. Dissociation of nitric oxide from soluble guanylate cyclase and heme-nitric oxide/oxygen binding domain constructs.
Winger JA; Derbyshire ER; Marletta MA
J Biol Chem; 2007 Jan; 282(2):897-907. PubMed ID: 17098738
[TBL] [Abstract][Full Text] [Related]
6. YC-1 activation of human soluble guanylyl cyclase has both heme-dependent and heme-independent components.
Martin E; Lee YC; Murad F
Proc Natl Acad Sci U S A; 2001 Nov; 98(23):12938-42. PubMed ID: 11687640
[TBL] [Abstract][Full Text] [Related]
7. Probing soluble guanylate cyclase activation by CO and YC-1 using resonance Raman spectroscopy.
Ibrahim M; Derbyshire ER; Marletta MA; Spiro TG
Biochemistry; 2010 May; 49(18):3815-23. PubMed ID: 20353168
[TBL] [Abstract][Full Text] [Related]
8. YC-1 binding to the β subunit of soluble guanylyl cyclase overcomes allosteric inhibition by the α subunit.
Purohit R; Fritz BG; The J; Issaian A; Weichsel A; David CL; Campbell E; Hausrath AC; Rassouli-Taylor L; Garcin ED; Gage MJ; Montfort WR
Biochemistry; 2014 Jan; 53(1):101-14. PubMed ID: 24328155
[TBL] [Abstract][Full Text] [Related]
9. [Nitric oxide. Potentiation of NO-dependent activation of soluble guanylate cyclase--(patho)physiological and pharmacotherapeutical significance].
Severina IS
Biomed Khim; 2007; 53(4):385-99. PubMed ID: 18035720
[TBL] [Abstract][Full Text] [Related]
10. Role of conformational changes in the heme-dependent regulation of human soluble guanylate cyclase.
Kosarikov DN; Lee JM; Uversky VN; Counts Gerber N
J Inorg Biochem; 2001 Dec; 87(4):267-76. PubMed ID: 11744065
[TBL] [Abstract][Full Text] [Related]
11. Purified soluble guanylyl cyclase expressed in a baculovirus/Sf9 system: stimulation by YC-1, nitric oxide, and carbon monoxide.
Hoenicka M; Becker EM; Apeler H; Sirichoke T; Schröder H; Gerzer R; Stasch JP
J Mol Med (Berl); 1999 Jan; 77(1):14-23. PubMed ID: 9930922
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of 1-benzyl-3-(5'-hydroxymethyl-2'-furyl)indazole analogues as novel antiplatelet agents.
Lee FY; Lien JC; Huang LJ; Huang TM; Tsai SC; Teng CM; Wu CC; Cheng FC; Kuo SC
J Med Chem; 2001 Oct; 44(22):3746-9. PubMed ID: 11606139
[TBL] [Abstract][Full Text] [Related]
13. Soluble guanylyl cyclase activator YC-1 inhibits human neutrophil functions through a cGMP-independent but cAMP-dependent pathway.
Hwang TL; Hung HW; Kao SH; Teng CM; Wu CC; Cheng SJ
Mol Pharmacol; 2003 Dec; 64(6):1419-27. PubMed ID: 14645672
[TBL] [Abstract][Full Text] [Related]
14. Soluble guanylate cyclase is activated differently by excess NO and by YC-1: resonance Raman spectroscopic evidence.
Ibrahim M; Derbyshire ER; Soldatova AV; Marletta MA; Spiro TG
Biochemistry; 2010 Jun; 49(23):4864-71. PubMed ID: 20459051
[TBL] [Abstract][Full Text] [Related]
15. Resonance Raman study on synergistic activation of soluble guanylate cyclase by imidazole, YC-1 and GTP.
Pal B; Li Z; Ohta T; Takenaka S; Tsuyama S; Kitagawa T
J Inorg Biochem; 2004 May; 98(5):824-32. PubMed ID: 15134928
[TBL] [Abstract][Full Text] [Related]
16. Insight into the rescue of oxidized soluble guanylate cyclase by the activator cinaciguat.
Surmeli NB; Marletta MA
Chembiochem; 2012 May; 13(7):977-81. PubMed ID: 22474005
[TBL] [Abstract][Full Text] [Related]
17. [YC-1-like potentiation of nitric oxide-dependent activation of soluble guanylyl cyclase by adrenochrome].
Severina IS; Piatakova NV; Shchegolev AIu; Sidorova TA
Biomed Khim; 2008; 54(6):679-86. PubMed ID: 19205427
[TBL] [Abstract][Full Text] [Related]
18. YC-1 potentiates cAMP-induced CREB activation and nitric oxide production in alveolar macrophages.
Hwang TL; Tang MC; Kuo LM; Chang WD; Chung PJ; Chang YW; Fang YC
Toxicol Appl Pharmacol; 2012 Apr; 260(2):193-200. PubMed ID: 22381622
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of YC-1-induced activation of soluble guanylyl cyclase.
Friebe A; Koesling D
Mol Pharmacol; 1998 Jan; 53(1):123-7. PubMed ID: 9443939
[TBL] [Abstract][Full Text] [Related]
20. Kinetics and equilibria of soluble guanylate cyclase ligation by CO: effect of YC-1.
Kharitonov VG; Sharma VS; Magde D; Koesling D
Biochemistry; 1999 Aug; 38(33):10699-706. PubMed ID: 10451364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
